Women, Breast Cancer, Schizophrenia & Psychotropics

The Lancet Psychiatry gives a startling and important summary concerning the link between breast cancer in adult females and their schizophrenia diagnosis in, “Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland – The Lancet Psychiatry” (Taipale, Solmi, Lahteenvuo, Tanskanen, Correll & Tiihonen, 2021).

Vikki

Reference

Taipale, H., PhD., Solmi, M., PhD., Lahteenvuo, M., PhD., Tanskanen, A., Ph.D., Correll, C. U., Ph.D., & Tiihonen, J., PhD. (2021). Antipsychotic Use And Risk Of Breast Cancer In Women With Schizophrenia: A Nationwide Nested Case-Control Study In Finland. The Lancet Psychiatry, 8(10), (pp. 883 – 891). Retrieved From Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland – The Lancet Psychiatry

*The adult male population is not immune from a breast cancer diagnosis!